| Brand | Active ingredient | Application holder | Expiry | Excl. |
|---|---|---|---|---|
| ABILIFY ASIMTUFII | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 23 Apr | - |
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 24 Sept | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 15 Oct | - |
| ACZONE | DAPSONE | ALMIRALL LLC | 18 Nov | - |
| AGAMREE | VAMOROLONE | CATALYST PHARMACEUTICALS INC | 07 Mar | ODE-450 |
| AKLIEF | TRIFAROTENE | GALDERMA LABORATORIES LP | 30 May | - |
| ALKINDI SPRINKLE | HYDROCORTISONE | ETON PHARMACEUTICALS INC | 10 Jan | - |
| ALYFTREK | DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM | VERTEX PHARMACEUTICALS INC | 15 Jul | ODE-536 |
| ANTARA (MICRONIZED) | FENOFIBRATE | LUPIN INC | 31 May | - |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 19 Sept | - |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 24 Oct | - |
| ARYMO ER | MORPHINE SULFATE | ZYLA LIFE SCIENCES US INC | 01 Jul | - |
| ATZUMI | DIHYDROERGOTAMINE MESYLATE | SATSUMA PHARMACEUTICALS INC | 24 Sept | NP |
| AUSTEDO | DEUTETRABENAZINE | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC | 18 Sept | - |
| AUSTEDO XR | DEUTETRABENAZINE | TEVA NEUROSCIENCE INC | 18 Sept | - |
| BALVERSA | ERDAFITINIB | JANSSEN BIOTECH INC | 12 Apr | I-930 |
| BAXDELA | DELAFLOXACIN MEGLUMINE | MELINTA SUBSIDIARY CORP | 27 Feb | GAIN |
| BAXFENDY | BAXDROSTAT | ASTRAZENECA AB | 04 Feb | NCE |
| BELSOMRA | SUVOREXANT | MERCK SHARP AND DOHME CORP | 29 May | - |
| BENDEKA | BENDAMUSTINE HYDROCHLORIDE | EAGLE PHARMACEUTICALS INC | 15 Mar | - |
| BIKTARVY | BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Feb | ODE-540 |
| BIKTARVY | BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 19 Dec | ODE-540 |
| BONJESTA | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE | DUCHESNAY INC | 18 Feb | - |
| BRAFTOVI | ENCORAFENIB | ARRAY BIOPHARMA INC | 05 Aug | ODE-445 |
| BYFAVO | REMIMAZOLAM BESYLATE | ACACIA PHARMA LTD | 30 Apr | - |
| CABOMETYX | CABOZANTINIB S-MALATE | EXELIXIS INC | 09 Jul | ODE-530 |
| CAPLYTA | LUMATEPERONE TOSYLATE | INTRA-CELLULAR THERAPIES INC | 19 Aug | M-319 |
| CARNEXIV | CARBAMAZEPINE | LUNDBECK PHARMACEUTICALS LLC | 27 Feb | - |
| CEQUA | CYCLOSPORINE | SUN PHARMACEUTICAL INDUSTRIES LTD | 23 Aug | - |
| CLOROTEKAL | CHLOROPROCAINE HYDROCHLORIDE | B BRAUN MEDICAL INC | 11 Dec | - |
| COMPLERA | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE | GILEAD SCIENCES INC | 14 Jan | - |
| CONTRAVE | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 05 Jun | - |
| CONTRAVE | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 25 Jun | - |
| CYTALUX | PAFOLACIANINE SODIUM | ON TARGET LABORATORIES INC | 26 Aug | ODE-390 |
| CYTALUX | PAFOLACIANINE SODIUM | ON TARGET LABORATORIES INC | 04 Oct | ODE-390 |
| DAPTOMYCIN | DAPTOMYCIN | HOSPIRA INC | 11 Sept | - |
| DESCOVY | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Feb | ODE-556 |
| DETECTNET | COPPER CU-64 DOTATATE | CURIUM US LLC | 02 Jul | ODE-317 |
| DOCETAXEL | DOCETAXEL | SHILPA MEDICARE LTD | 30 Sept | - |
| EMPAVELI | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 13 Jan | ODE-533 |
| EMPAVELI | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 02 Aug | ODE-533 |
| EMPAVELI | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 15 Nov | ODE-533 |
| ENTRESTO | SACUBITRIL; VALSARTAN | NOVARTIS PHARMACEUTICALS CORP | 22 Aug | - |
| EPANOVA | OMEGA-3-CARBOXYLIC ACIDS | ASTRAZENECA PHARMACEUTICALS LP | 04 Jan | - |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | GILEAD SCIENCES INC | 16 May | PED |
| ERLEADA | APALUTAMIDE | JANSSEN BIOTECH INC | 04 Jun | - |
| ERLEADA | APALUTAMIDE | JANSSEN BIOTECH INC | 23 Sept | - |
| ESBRIET | PIRFENIDONE | LEGACY PHARMA INC SEZC | 30 Aug | - |
| ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | ESMOLOL HYDROCHLORIDE | HQ SPECIALTY PHARMA CORP | 15 Mar | - |
| ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER | ESMOLOL HYDROCHLORIDE | HQ SPECIALTY PHARMA CORP | 15 Mar | - |
| EVOMELA | MELPHALAN HYDROCHLORIDE | ACROTECH BIOPHARMA INC | 27 Feb | - |
| EVRYSDI | RISDIPLAM | GENENTECH INC | 08 Feb | M-270 |
| EYSUVIS | LOTEPREDNOL ETABONATE | ALCON LABORATORIES INC | 03 May | - |
| FETROJA | CEFIDEROCOL SULFATE TOSYLATE | SHIONOGI INC | 14 Nov | GAIN |
| FINTEPLA | FENFLURAMINE HYDROCHLORIDE | UCB INC | 03 May | PED |
| FINTEPLA | FENFLURAMINE HYDROCHLORIDE | UCB INC | 03 Nov | PED |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Feb | - |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 06 Apr | - |
| GIVLAARI | GIVOSIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 15 Mar | ODE-273 |
| GIVLAARI | GIVOSIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 30 Nov | ODE-273 |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 14 Mar | ODE-262 |
| HEPZATO | MELPHALAN HYDROCHLORIDE | DELCATH SYSTEMS INC | 16 Jan | ODE-438 |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 25 Jan | ODE-330 |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 07 Apr | ODE-330 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 25 Jan | ODE-329 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 07 Apr | ODE-329 |
| IBSRELA | TENAPANOR HYDROCHLORIDE | ARDELYX INC | 01 Aug | - |
| IBTROZI | TALETRECTINIB ADIPATE | NUVATION BIO INC | 03 Jun | ODE-544 |
| ICLUSIG | PONATINIB HYDROCHLORIDE | TAKEDA PHARMACEUTICALS USA INC | 12 Dec | ODE-472 |
| IDHIFA | ENASIDENIB MESYLATE | BRISTOL MYERS SQUIBB | 07 Jan | - |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 03 Jun | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 18 Aug | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 30 Oct | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 03 Dec | PED |
| INBRIJA | LEVODOPA | MERZ PHARMACEUTICALS LLC | 21 Oct | - |
| INFUGEM | GEMCITABINE HYDROCHLORIDE | SUN PHARMACEUTICAL INDUSTRIES LTD | 01 Jul | - |
| INVELTYS | LOTEPREDNOL ETABONATE | ALCON LABORATORIES INC | 03 May | - |
| IONSYS | FENTANYL HYDROCHLORIDE | THE MEDICINES CO | 03 Feb | - |
| ISTURISA | OSILODROSTAT PHOSPHATE | RECORDATI RARE DISEASES INC | 20 May | ODE-535 |
| JAKAFI XR | RUXOLITINIB PHOSPHATE | INCYTE CORP | 14 Nov | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 22 Apr | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 22 Oct | PED |
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 06 Mar | PED |
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 06 Sept | PED |
| KALYDECO | IVACAFTOR | VERTEX PHARMACEUTICALS INC | 27 Feb | PED |
| KALYDECO | IVACAFTOR | VERTEX PHARMACEUTICALS INC | 27 Aug | PED |
| KENGREAL | CANGRELOR | CHIESI USA INC | 09 Mar | - |
| KERENDIA | FINERENONE | BAYER HEALTHCARE PHARMACEUTICALS INC | 26 Aug | NS |
| KORLYM | MIFEPRISTONE | CORCEPT THERAPEUTICS INC | 05 Mar | - |
| KUVAN | SAPROPTERIN DIHYDROCHLORIDE | BIOMARIN PHARMACEUTICAL INC | 01 May | - |
| KYPROLIS | CARFILZOMIB | ONYX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF AMGEN INC | 27 Feb | PED |
| KYPROLIS | CARFILZOMIB | ONYX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF AMGEN INC | 27 Aug | PED |
| KYZATREX | TESTOSTERONE UNDECANOATE | MARIUS PHARMACEUTICALS INC | 15 Mar | - |
| LIFYORLI (COPACKAGED) | RELACORILANT | CORCEPT THERAPEUTICS INC | 24 May | NCE |
| LILETTA | LEVONORGESTREL | MEDICINES360 | 06 Oct | I-917 |
| LILETTA | LEVONORGESTREL | MEDICINES360 | 24 Oct | I-917 |
| LINZESS | LINACLOTIDE | ABBVIE INC | 16 Aug | NPP |
| LODOCO | COLCHICINE | AGEPHA PHARMA FZ LLC | 01 Nov | - |
| LOKELMA | SODIUM ZIRCONIUM CYCLOSILICATE | ASTRAZENECA PHARMACEUTICALS LP | 22 Oct | - |
| LONHALA MAGNAIR KIT | GLYCOPYRROLATE | SUMITOMO PHARMA AMERICA INC | 16 May | - |
| LORBRENA | LORLATINIB | PFIZER INC | 05 Mar | ODE-349 |
| LUZU | LULICONAZOLE | BAUSCH HEALTH US LLC | 06 Sept | - |
| LYBALVI | OLANZAPINE; SAMIDORPHAN L-MALATE | ALKERMES INC | 31 May | NCE |
| LYTGOBI | FUTIBATINIB | TAIHO ONCOLOGY INC | 13 Feb | ODE-410 |
| MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | NOVARTIS PHARMACEUTICALS CORP | 30 Aug | PED |
| MEKTOVI | BINIMETINIB | ARRAY BIOPHARMA INC | 18 Oct | I-928 |
| MEZOFY | ARIPIPRAZOLE | CMG PHARMACEUTICAL CO LTD | 07 Aug | - |
| MIEBO | PERFLUOROHEXYLOCTANE | BAUSCH AND LOMB INC | 12 Sept | NCE |
| MITIGARE | COLCHICINE | HIKMA INTERNATIONAL PHARMACEUTICALS LLC | 22 Aug | - |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 09 Apr | NP |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 18 Oct | NP |
| MYFEMBREE | ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX | SUMITOMO PHARMA AMERICA INC | 27 Sept | M-289 |
| NAFTIN | NAFTIFINE HYDROCHLORIDE | LEGACY PHARMA INC SEZC | 31 Jan | - |
| NATROBA | SPINOSAD | CIPHER PHARMACEUTICALS INC | 25 Nov | - |
| NEXTERONE | AMIODARONE HYDROCHLORIDE | BAXTER HEALTHCARE CORP | 27 Feb | - |
| NOXAFIL | POSACONAZOLE | MERCK SHARP AND DOHME CORP | 27 Feb | NPP |
| NUBEQA | DAROLUTAMIDE | BAYER HEALTHCARE PHARMACEUTICALS INC | 25 Mar | I-971 |
| NURTEC ODT | RIMEGEPANT SULFATE | PFIZER INC | 25 Feb | - |
| OCALIVA | OBETICHOLIC ACID | INTERCEPT PHARMACEUTICALS INC | 17 Jun | - |
| OCALIVA | OBETICHOLIC ACID | INTERCEPT PHARMACEUTICALS INC | 06 Sept | - |
| ODEFSEY | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Feb | - |
| OMIDRIA | KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE | RAYNER SURGICAL INC | 23 Oct | - |
| ONIVYDE | IRINOTECAN HYDROCHLORIDE | IPSEN BIOPHARMACEUTICALS INC | 12 Jun | ODE-463 |
| ONZETRA XSAIL | SUMATRIPTAN SUCCINATE | AZURITY PHARMACEUTICALS INC | 04 Nov | - |
| OPFOLDA | MIGLUSTAT | AMICUS THERAPEUTICS US LLC | 07 Mar | NP |
| ORFADIN | NITISINONE | SWEDISH ORPHAN BIOVITRUM AB PUBL | 28 Feb | - |
| ORGOVYX | RELUGOLIX | SUMITOMO PHARMA AMERICA INC | 27 Sept | - |
| OTEZLA | APREMILAST | AMGEN INC | 30 Nov | PED |
| OXBRYTA | VOXELOTOR | GLOBAL BLOOD THERAPEUTICS INC | 25 Nov | ODE-394 |
| OZEMPIC | SEMAGLUTIDE | NOVO NORDISK INC | 19 Jun | I-976 |
| OZEMPIC | SEMAGLUTIDE | NOVO NORDISK INC | 21 Jun | I-961 |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | PARAGON BIOTECK INC | 14 Nov | - |
| PHEXX | CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE | EVOFEM INC | 15 Mar | - |
| PICATO | INGENOL MEBUTATE | LEO LABORATORIES LTD | 15 May | - |
| PIQRAY | ALPELISIB | NOVARTIS PHARMACEUTICALS CORP | 29 Apr | I-937 |
| PLENVU | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | SALIX PHARMACEUTICALS INC | 10 Sept | - |
| PREVYMIS | LETERMOVIR | MERCK SHARP AND DOHME CORP | 28 Feb | ODE-495 |
| PROLENSA | BROMFENAC SODIUM | BAUSCH AND LOMB INC | 11 Nov | - |
| PYRUKYND | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 12 Apr | ODE-392 |
| QBREXZA | GLYCOPYRRONIUM TOSYLATE | JOURNEY MEDICAL CORP | 28 Feb | - |
| QELBREE | VILOXAZINE HYDROCHLORIDE | SUPERNUS PHARMACEUTICALS INC | 07 Feb | NCE |
| QFITLIA | FITUSIRAN SODIUM | GENZYME CORP | 15 Mar | ODE-510 |
| QFITLIA | FITUSIRAN SODIUM | GENZYME CORP | 22 Mar | ODE-510 |
| QUDEXY XR | TOPIRAMATE | UPSHER SMITH LABORATORIES LLC | 19 Mar | - |
| QUILLICHEW ER | METHYLPHENIDATE HYDROCHLORIDE | NEXTWAVE PHARMACEUTICALS INC | 14 Aug | - |
| QULIPTA | ATOGEPANT | ABBVIE INC | 13 Mar | NCE |
| QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | IDORSIA PHARMACEUTICALS LTD | 03 Jun | M-200 |
| RECARBRIO | CILASTATIN SODIUM; IMIPENEM; RELEBACTAM | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 21 Mar | GAIN |
| RELYVRIO | SODIUM PHENYLBUTYRATE; TAURURSODIOL | AMYLYX PHARMACEUTICALS INC | 24 Dec | ODE-411 |
| REXULTI | BREXPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 12 Apr | M-315 |
| REZDIFFRA | RESMETIROM | MADRIGAL PHARMACEUTICALS INC | 17 Sept | NCE |
| REZUROCK | BELUMOSUDIL MESYLATE | KADMON PHARMACEUTICALS LLC | 07 Oct | ODE-362 |
| REZZAYO | REZAFUNGIN ACETATE | MUNDIPHARMA GMBH | 14 Mar | GAIN |
| RINVOQ | UPADACITINIB | ABBVIE INC | 16 Aug | ODE-481 |
| RINVOQ LQ | UPADACITINIB | ABBVIE INC | 16 Aug | ODE-481 |
| ROSZET | EZETIMIBE; ROSUVASTATIN CALCIUM | ALTHERA PHARMACEUTICALS LLC | 01 May | - |
| ROZLYTREK | ENTRECTINIB | GENENTECH INC | 22 May | ODE-448 |
| RYBELSUS | SEMAGLUTIDE | NOVO NORDISK INC | 15 Mar | I-976 |
| RYBELSUS | SEMAGLUTIDE | NOVO NORDISK INC | 19 Jun | I-976 |
| RYTELO | IMETELSTAT SODIUM | GERON CORP | 15 Mar | ODE-482 |
| SCENESSE | AFAMELANOTIDE | CLINUVEL INC | 20 Jan | ODE-270 |
| SECUADO | ASENAPINE | HISAMITSU PHARMACEUTICAL CO INC | 25 Jul | - |
| SECUADO | ASENAPINE | HISAMITSU PHARMACEUTICAL CO INC | 22 Sept | - |
| SESQUIENT | FOSPHENYTOIN SODIUM | LUPIN INC | 27 Feb | - |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | ALMIRALL LLC | 09 Feb | - |
| SKYCLARYS | OMAVELOXOLONE | BIOGEN US CORPORATION | 24 Apr | ODE-427 |
| SOAANZ | TORSEMIDE | SARFEZ PHARMACEUTICALS INC | 06 Oct | - |
| SOTYKTU | DEUCRAVACITINIB | BRISTOL MYERS SQUIBB CO | 07 Nov | I-986 |
| SPRAVATO | ESKETAMINE HYDROCHLORIDE | JANSSEN PHARMACEUTICALS INC | 05 Mar | I-959 |
| STRIBILD | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | GILEAD SCIENCES INC | 06 Apr | - |
| SYFOVRE | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 13 Jan | NCE |
| SYFOVRE | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 02 Aug | NCE |
| SYFOVRE | PEGCETACOPLAN | APELLIS PHARMACEUTICALS INC | 15 Nov | NCE |
| SYMDEKO (COPACKAGED) | IVACAFTOR; IVACAFTOR, TEZACAFTOR | VERTEX PHARMACEUTICALS INC | 15 Jul | ODE-335 |
| SYMPROIC | NALDEMEDINE TOSYLATE | BIODELIVERY SCIENCES INTERNATIONAL INC | 13 May | - |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 22 Apr | PED |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 22 Oct | PED |
| TAFINLAR | DABRAFENIB MESYLATE | NOVARTIS PHARMACEUTICALS CORP | 30 Aug | PED |
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EPIZYME INC | 11 Apr | ODE-314 |
| TIBSOVO | IVOSIDENIB | SERVIER PHARMACEUTICALS LLC | 18 Jan | ODE-447 |
| TIBSOVO | IVOSIDENIB | SERVIER PHARMACEUTICALS LLC | 19 Aug | ODE-447 |
| TIGECYCLINE | TIGECYCLINE | AMNEAL PHARMACEUTICALS LLC | 07 Apr | - |
| TOLSURA | ITRACONAZOLE | MAYNE PHARMA INTERNATIONAL PTY LTD | 21 Jun | - |
| TRIKAFTA (COPACKAGED) | ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR | VERTEX PHARMACEUTICALS INC | 27 Feb | ODE-543 |
| TRIKAFTA (COPACKAGED) | ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR | VERTEX PHARMACEUTICALS INC | 15 Jul | ODE-543 |
| TRUDHESA | DIHYDROERGOTAMINE MESYLATE | IMPEL PHARMACEUTICALS LLC | 23 Jan | - |
| TRUDHESA | DIHYDROERGOTAMINE MESYLATE | IMPEL PHARMACEUTICALS LLC | 17 Mar | - |
| TRUQAP | CAPIVASERTIB | ASTRAZENECA PHARMACEUTICALS LP | 16 Apr | I-991 |
| TUKYSA | TUCATINIB | SEAGEN INC | 25 Mar | ODE-422 |
| TURALIO | PEXIDARTINIB HYDROCHLORIDE | DAIICHI SANKYO INC | 04 May | ODE* |
| TURALIO | PEXIDARTINIB HYDROCHLORIDE | DAIICHI SANKYO INC | 08 Jun | ODE* |
| TYBOST | COBICISTAT | GILEAD SCIENCES INC | 06 Apr | NS |
| UBRELVY | UBROGEPANT | ABBVIE INC | 23 Dec | - |
| UKONIQ | UMBRALISIB TOSYLATE | TG THERAPEUTICS INC | 02 Jul | NCE |
| ULTRAVATE | HALOBETASOL PROPIONATE | LACER PHARMA LLC | 19 Jun | - |
| UZEDY | RISPERIDONE | TEVA NEUROSCIENCE INC | 05 Apr | NP |
| VANFLYTA | QUIZARTINIB DIHYDROCHLORIDE | DAIICHI SANKYO INC | 30 Sept | ODE-437 |
| VASCEPA | ICOSAPENT ETHYL | AMARIN PHARMACEUTICALS IRELAND LTD | 28 Jun | - |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 18 May | PED |
| VELTASSA | PATIROMER SORBITEX CALCIUM | VIFOR PHARMA INC | 08 Oct | NS |
| VEMLIDY | TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Feb | NPP |
| VENCLEXTA | VENETOCLAX | ABBVIE INC | 06 Sept | ODE-239 |
| VIBERZI | ELUXADOLINE | ABBVIE INC | 14 Mar | - |
| VIEKIRA PAK (COPACKAGED) | DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR | ABBVIE INC | 18 Oct | - |
| VIJOICE | ALPELISIB | NOVARTIS PHARMACEUTICALS CORP | 29 Apr | - |
| VIVJOA | OTESECONAZOLE | MYCOVIA PHARMACEUTICALS INC | 09 May | GAIN |
| VIVLODEX | MELOXICAM | ICEUTICA OPERATIONS LLC | 31 Mar | - |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 16 May | - |
| VUMERITY | DIROXIMEL FUMARATE | BIOGEN INC | 20 Sept | - |
| VUMERITY | DIROXIMEL FUMARATE | BIOGEN INC | 29 Oct | - |
| VYBRIQUE | SILDENAFIL CITRATE | IBSA INSTITUT BIOCHIMIQUE SA | 16 Dec | NP |
| VYLEESI (AUTOINJECTOR) | BREMELANOTIDE ACETATE | COSETTE PHARMACEUTICALS INC | 05 Nov | - |
| VYXEOS | CYTARABINE; DAUNORUBICIN | JAZZ PHARMACEUTICALS THERAPEUTICS INC | 15 Apr | PED |
| WAYRILZ | RILZABRUTINIB | GENZYME CORP | 01 Mar | ODE-552 |
| WAYRILZ | RILZABRUTINIB | GENZYME CORP | 06 Sept | ODE-552 |
| WEGOVY | SEMAGLUTIDE | NOVO NORDISK INC | 19 Jun | NP |
| WEGOVY | SEMAGLUTIDE | NOVO NORDISK INC | 21 Jun | - |
| WEGOVY FLEXTOUCH | SEMAGLUTIDE | NOVO NORDISK INC | 21 Jun | I-973 |
| WEGOVY HD | SEMAGLUTIDE | NOVO NORDISK INC | 21 Jun | NS |
| XACDURO (COPACKAGED) | DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM | ENTASIS THERAPEUTICS INC | 02 Apr | GAIN |
| XARACOLL | BUPIVACAINE HYDROCHLORIDE | INNOCOLL PHARMACEUTICALS | 09 Jan | - |
| XATMEP | METHOTREXATE SODIUM | AZURITY PHARMACEUTICALS INC | 02 Jan | - |
| XELSTRYM | DEXTROAMPHETAMINE | NOVEN PHARMACEUTICALS INC | 24 Oct | - |
| XENLETA | LEFAMULIN ACETATE | HONG KONG KING FRIEND INDUSTRIAL CO LTD | 25 Mar | GAIN |
| XIIDRA | LIFITEGRAST | BAUSCH AND LOMB INC | 25 Jul | - |
| XIIDRA | LIFITEGRAST | BAUSCH AND LOMB INC | 18 Dec | - |
| XIPERE | TRIAMCINOLONE ACETONIDE | BAUSCH AND LOMB INC | 08 Nov | - |
| XPHOZAH | TENAPANOR HYDROCHLORIDE | ARDELYX INC | 01 Aug | NP |
| XPOVIO | SELINEXOR | KARYOPHARM THERAPEUTICS INC | 03 Jul | ODE* |
| XTANDI | ENZALUTAMIDE | ASTELLAS PHARMA US INC | 11 Sept | I-926 |
| XTORO | FINAFLOXACIN | FONSECA BIOSCIENCES LLC | 21 Nov | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 04 Jun | - |
| XYREM | SODIUM OXYBATE | JAZZ PHARMACEUTICALS INC | 15 Mar | PED |
| XYREM | SODIUM OXYBATE | JAZZ PHARMACEUTICALS INC | 15 Sept | PED |
| XYWAV | CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE | JAZZ PHARMACEUTICALS IRELAND LTD | 11 Jan | ODE-369 |
| XYWAV | CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE | JAZZ PHARMACEUTICALS IRELAND LTD | 15 Mar | ODE-369 |
| XYWAV | CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE | JAZZ PHARMACEUTICALS IRELAND LTD | 15 Sept | ODE-369 |
| YOSPRALA | ASPIRIN; OMEPRAZOLE | GENUS LIFE SCIENCES INC | 02 Jan | - |
| YOSPRALA | ASPIRIN; OMEPRAZOLE | GENUS LIFE SCIENCES INC | 13 Mar | - |
| ZAYNICH | CEFEPIME HYDROCHLORIDE; ZIDEBACTAM | WOCKHARDT BIO AG | 12 Oct | GAIN |
| ZEPOSIA | OZANIMOD HYDROCHLORIDE | BRISTOL MYERS SQUIBB CO | 24 Mar | M-309 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 07 Mar | PED |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | HARROW EYE LLC | 09 Jan | - |
| ZOHYDRO ER | HYDROCODONE BITARTRATE | RECRO GAINESVILLE LLC | 25 Jul | - |
| ZULRESSO | BREXANOLONE | SAGE THERAPEUTICS LLC A WHOLLY OWNED SUB OF SUPERNUS PHARMACEUTICALS INC | 23 Jan | - |
| ZULRESSO | BREXANOLONE | SAGE THERAPEUTICS LLC A WHOLLY OWNED SUB OF SUPERNUS PHARMACEUTICALS INC | 27 Nov | - |
| ZYDELIG | IDELALISIB | GILEAD SCIENCES INC | 05 Mar | - |
| ZYDELIG | IDELALISIB | GILEAD SCIENCES INC | 02 Sept | - |
Provenance
Source: FDA Orange Book patent and exclusivity files. Rows carrying an exclusivity code have a separate regulatory exclusivity that can outlast the patent shown. Patent expiry alone does not determine when a generic can launch: paediatric extensions, 30-month stays and settlement agreements frequently move the effective date. Delisted patents are excluded.